Royal Brompton Hospital cafe renamed to honour manager
A west London hospital cafe has been renamed in honour of its long‑serving manager who, according his bosses,…
Mitrix moves mitochondria into the clinic
Early human safety data and new US clinics signal a shift from theory to real-world testing for mitochondrial…
Private firms providing services to NHS made £1.6bn profit in two years, research finds | NHS
Private firms providing services to the NHS including healthcare and consultancy have made £1.6bn in profits over the…
New alert as important NHS document to expire for millions – how to stop it
Nearly 800,000 are due to run out during peak summer holiday months Charlotte Smith Senior Lifestyle Content Editor…
Pancreatic cancer drug daraxonrasib from Revolution Medicines succeeds in trial
Pancreatic cancer, illustration Nemes Laszl | Science Photo Library | Getty Images Revolution Medicines‘ drug for pancreatic cancer…
NHS Scotland-linked domains push pr0n and illegal streams • The Register
Multiple domains belonging to Scottish healthcare providers have been hijacked and are now pushing links to adult content…
Is This Biotech Stock the Best Chance to Make a Fortune in Healthcare?
Investing in smaller biotechs can yield outstanding returns over the long run if they make sufficient regulatory and…
How Merck turned its wonder drug into a blockbuster — and priced out cancer patients worldwide
Just days before Christmas 2025, leaders of nine pharmaceutical companies clustered in the Roosevelt Room of the White…
8 Healthcare Stocks Insiders Are Buying
When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were…
CDC Caught Burying Report on Real Effects of COVID Vaccine
Sign up to see the future, today Can’t-miss innovations from the bleeding edge of science and tech The…
How The Narrative On Johnson & Johnson (JNJ) Is Shifting With New Targets And Litigation Risks
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
Johnson & Johnson Vs. Pfizer
As large tech companies struggled this year, investors have had a chance to reevaluate their portfolios and identify…